FMO5 and myeloid sarcoma: As oxidative stress in MS lesions has already been studied before, our study focused on non‐MS inflammatory and demyelinating conditions to examine oxidative stress with regard to the expression of p22phox, a subunit of NADPH oxidase and the occurrence of oxidized phospholipids (E06) as a marker for oxidative tissue injury.